Structure-activity relationships of trimethoxybenzyl piperazine N-type calcium channel inhibitors
We previously reported the small organic N-type calcium channel blocker NP078585 that while efficacious in animal models for pain, exhibited modest L-type calcium channel selectivity and substantial off-target inhibition against the hERG potassium channel